Evidence map›Paper›PMID 39900361›Full record

ArticleCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2025

Mortality and hospitalizations fully attributable to alcohol use before versus during the COVID-19 pandemic in Canada.

Yipu Shi, Kathryn Macrae, Margaret de Groh, Wendy Thompson, Tim Stockwell

Abstract read
In one paragraph

Article in CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. COVID-19 in Rural Ontario Communities: Exploring Women's Mental Health During a Pandemic.International journal of environmental research and public health · 2025
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yipu ShiCentre for Surveillance and Applied Research (Shi, Macrae, de Groh, Thompson), Public Health Agency of Canada, Ottawa, Ont.; Canadian Institute for Substance Use Research (Stockwell), University of Victoria, Victoria, BC. yipu.shi@phac-aspc.gc.ca.
Kathryn MacraeCentre for Surveillance and Applied Research (Shi, Macrae, de Groh, Thompson), Public Health Agency of Canada, Ottawa, Ont.; Canadian Institute for Substance Use Research (Stockwell), University of Victoria, Victoria, BC.
Margaret de GrohCentre for Surveillance and Applied Research (Shi, Macrae, de Groh, Thompson), Public Health Agency of Canada, Ottawa, Ont.; Canadian Institute for Substance Use Research (Stockwell), University of Victoria, Victoria, BC.
Wendy ThompsonCentre for Surveillance and Applied Research (Shi, Macrae, de Groh, Thompson), Public Health Agency of Canada, Ottawa, Ont.; Canadian Institute for Substance Use Research (Stockwell), University of Victoria, Victoria, BC.
Tim StockwellCentre for Surveillance and Applied Research (Shi, Macrae, de Groh, Thompson), Public Health Agency of Canada, Ottawa, Ont.; Canadian Institute for Substance Use Research (Stockwell), University of Victoria, Victoria, BC.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic period was associated with increased alcohol consumption. We sought to estimate excess mortality and hospitalizations attributable to alcohol use in Canada between April 2020 and December 2022.

methodsUsing data from the Canadian Vital Statistics Database and hospital Discharge Abstract Database (Jan. 2016 to Dec. 2022), we analyzed monthly mortality and hospitalization rates for conditions fully attributable to alcohol use in people in Canada aged 15 years and older. We estimated excess rates during the study period of April 2020 to December 2022 by comparing observed rates to expected rates, modelled using the autoregressive integrated moving average method, accounting for trends, seasonality, autocorrelation, and pandemic waves.

resultsBetween April 2020 and December 2022, mortality fully attributable to alcohol in Canada increased by 17.6% (1600 excess deaths), and hospitalizations fully attributable to alcohol rose by 8.1% (7142 excess hospitalizations). Most increases occurred in the first 2 years, with deaths up about 24% and hospitalizations about 14%. Mortality rose by 55.4% in adults aged 25-44 years, 19.1% in those aged 45-64 years, and 2.6% in those aged 65 years and older, with similar increases among males (17.0%) and females (17.8%). Deaths rose by 11.7% in the highest income quintile, as compared with 17.0%-21.5% in the other quintiles. Excess hospitalizations were highest among people aged 15-24 years (20.3%) and 25-44 years (13.1%) and increased more for females (15.6%) than for males (5.7%). Regionally, mortality increased most in the Prairie provinces (Manitoba, Saskatchewan, and Alberta; 28.1%) and British Columbia (24.2%), whereas hospitalizations increased the most in the territories (Northwest Territories, Nunavut, and Yukon; 27.3%) and the Prairie provinces (14.6%). Alcoholic liver disease was the leading cause of excess mortality and hospitalizations, which increased by 22% and 23%, respectively.

interpretationMortality and hospitalizations fully attributable to alcohol increased substantially across different demographics and regions in Canada during the April 2020 to December 2022 period of the COVID-19 pandemic. A comprehensive approach to preventing and managing high-risk drinking, alcohol use disorder, and alcoholic liver disease in the aftermath of the pandemic should comprise both public health and clinical management interventions.

Indexed as

Alcohol DrinkingCOVID-19HospitalizationAdolescentAdultAgedCanadaFemaleHumansMaleMiddle AgedPandemicsSARS-CoV-2Young Adult

Identifiers

PMID39900361
PMCPMC11790301

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.